v3.26.1
OTHER BENEFIT PLANS
12 Months Ended
Dec. 31, 2025
Postemployment Benefits [Abstract]  
OTHER BENEFIT PLANS OTHER BENEFIT PLANS
The Company has established a stock dividend reinvestment and stock purchase plan. Under the DRIP, eligible shareholders can voluntarily purchase stock with their dividend or can make additional stock purchases. For the year ended December 31, 2025 and December 31, 2024, there were no shares issued.
All employees and Directors are eligible to participate in the NSPP. Expense recognized in relation to the NSPP for the year ended December 31, 2025 and December 31, 2024 was $17 and $23, respectively. During the year ended December 31, 2025, 7,509 shares were purchased at an average price of $9.07. For the year ended December 31, 2024, there were no shares issued.
The Company has a Salary Continuation Agreement (the “Agreement”) with the Company’s retired CEO. In accordance with the Agreement, the executive will receive an annual benefit of $25 for twenty years following separation of service. The liability recorded for the Agreement was $316 and $327 at December 31, 2025 and December 31, 2024, respectively, and the related expense for the year ended December 31, 2025 was $14 and the related expense for the year ended December 31, 2024 was $1. Payments began in July 2024 as a result of the retirement of the CEO on December 31, 2023.
The Company has a 401(k) plan that covers all employees subject to certain age and service requirements. The Company contributes 3% of each employee’s salary each pay period as a safe harbor contribution. The Company may also match employee contributions each year at the discretion of the Board of Directors. There was no match of contributions in 2025 or 2024. Expense recognized in relation to the 401(k) plan was $835 and $961 for the year ended December 31, 2025 and December 31, 2024, respectively.

The Company had an ESOP for eligible employees with outstanding loans as a result of the acquisition of shares in 2021 and the termination of the nationwide residential lending division in 2022. On September 30, 2025, the Plan was terminated and the remaining 19,691 shares in the ESOP unallocated account with a fair value of $175 were returned to the Company in partial satisfaction of the outstanding balances on the ESOP loans. The ESOP accounts of the participants were 100% vested as of the date of the termination. As part of the termination of the plan, the Company forgave the indebtedness of the outstanding loans which totaled $365. There was $190 of expense related to the ESOP for the year ended December 31,
2025 and $43 expense for the year ended December 31, 2024. The Company’s ESOP, which was internally leveraged, did not report the loan receivable extended to the ESOP as an asset and did not report the ESOP debt due to the Company.